Sf9, Insect cells.
CD80 Molecule, CD80 Antigen (CD28 Antigen Ligand 1, B7-1 Antigen), B-Lymphocyte Activation Antigen B7, CTLA-4 Counter-Receptor B7.1, Activation B7-1 Antigen, CD28LG1, CD28LG, LAB7, BB1, B7, Costimulatory Molecule Variant IgV-CD80, T-Lymphocyte Activation Antigen CD80, Costimulatory Factor CD80, CD80 Antigen, B7-1, B7.1.
Greater than 95.0% as determined by SDS-PAGE.
CD80 Human Recombinant produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing 216 amino acids (35-242a.a.) and having a molecular mass of 24.9kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa).
CD80 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
CD80 Molecule, CD80 Antigen (CD28 Antigen Ligand 1, B7-1 Antigen), B-Lymphocyte Activation Antigen B7, CTLA-4 Counter-Receptor B7.1, Activation B7-1 Antigen, CD28LG1, CD28LG, LAB7, BB1, B7, Costimulatory Molecule Variant IgV-CD80, T-Lymphocyte Activation Antigen CD80, Costimulatory Factor CD80, CD80 Antigen, B7-1, B7.1.
Sf9, Insect cells.
VIHVTKEVKE VATLSCGHNV SVEELAQTRI YWQKEKKMVL TMMSGDMNIW PEYKNRTIFD ITNNLSIVIL ALRPSDEGTY ECVVLKYEKD AFKREHLAEV TLSVKADFPT PSISDFEIPT SNIRRIICST SGGFPEPHLS WLENGEELNA INTTVSQDPE TELYAVSSKL DFNMTTNHSF MCLIKYGHLR VNQTFNWNTT KQEHFPDNLE HHHHHH.
CD80, also known as B7-1, is a type I membrane protein that belongs to the immunoglobulin superfamily. It plays a crucial role in the regulation of T-cell activation and immune responses. CD80 is primarily expressed on antigen-presenting cells (APCs) such as dendritic cells, activated B-cells, and macrophages .
CD80 is a transmembrane glycoprotein with an extracellular domain that includes an immunoglobulin constant-like domain and a variable-like domain required for receptor binding . It is closely related to CD86 (B7-2), and both molecules often work in tandem to regulate immune responses .
The primary function of CD80 is to provide co-stimulatory signals necessary for T-cell activation and survival. It achieves this by binding to receptors on T-cells, specifically CD28 and CTLA-4. The interaction between CD80 and CD28 provides a positive co-stimulatory signal that promotes T-cell activation and proliferation. Conversely, the interaction between CD80 and CTLA-4 delivers an inhibitory signal that downregulates T-cell responses .
Recombinant CD80 is produced using various expression systems, including human embryonic kidney (HEK293) cells. The recombinant protein is typically tagged with a polyhistidine (His) tag to facilitate purification and detection . The recombinant form of CD80 retains its ability to bind to its receptors, making it a valuable tool for research and therapeutic applications.
Recombinant CD80 is widely used in immunological research to study T-cell activation and co-stimulation. It is also employed in the development of immunotherapies for cancer and autoimmune diseases. By modulating the interactions between CD80 and its receptors, researchers can influence immune responses to achieve therapeutic benefits .